Hepatitis C NS5B polymerase inhibitors: 4, 4-Dialkyl-1-hydroxy-3-oxo-3, 4-dihydronaphthalene-3-yl benzothiadiazine derivatives

DK Hutchinson, T Rosenberg, LL Klein…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 18, # 14 p. 3887 - 3890

Full Text: HTML

Citation Number: 15

Abstract

... Please enable JavaScript to use all the features on this page. Bioorganic & Medicinal Chemistry Letters. ... 4 and 5 Consequently there is a great medical need for new HCV chemotherapeutic agents that would give SVR against genotypes other than 2 or 3. ...

Related Articles:

Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1, 8-naphthyridon-3-yl …

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 14 p. 3833 - 3838]

Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1, 8-naphthyridon-3-yl …

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 14 p. 3833 - 3838]

Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1, 8-naphthyridon-3-yl …

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 14 p. 3833 - 3838]

Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the …

[Bioorganic and Medicinal Chemistry, , vol. 20, # 7 p. 2455 - 2478]

More Articles...